Table 1 Patient chararcteristics-patients receiving ASCT
Patients ≤ 60 years of age | Patients 61–65 years of age | |
|---|---|---|
N (%) | N (%) | |
M-Component | ||
IgG κ | 76 (36,1) | 31 (37,5) |
IgG λ | 24 (11,9) | 11 (13,8) |
IgA κ | 27 (12,0) | 13 15,9) |
IgA λ | 12 (6,6) | 7 (8,3) |
light chain κ | 42 (19,1) | 10 (13,2) |
light chain λ | 16 (7,3) | 5 (6,3) |
non secretory | 13 (6,0) | 2 (2,5) |
biclonal | 2 (1,0) | 0 (0) |
no information | 0 | 2 (2,5) |
Stage Durie&Salmon | ||
IA | 55 (26,4) | 22 (27,1) |
IB | 5 (2,4) | 2 (2,4) |
IIA | 82 (38,9) | 33 (41,0) |
IIB | 16 (7,4) | 4 (5,0) |
IIIA | 40 (18,5) | 17 (21,2) |
IIIB | 14 (6,4) | 3 (3,3) |
Stage ISS | ||
ISS I | 65 (31,0) | 21 (26,3) |
ISS II | 40 (18,5) | 18 (22,6) |
ISS III | 39 (18,1) | 19 (23,8) |
No information*) | 68 (32,4) | 23 (27,3) |